Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Irving Kirsch, Ph.D.

Co-Author

This page shows the publications co-authored by Irving Kirsch and Sarah Ballou.
Connection Strength

0.486
  1. Are they side effects? Extra-intestinal symptoms reported during clinical trials of IBS may be more severe at baseline. Clin Gastroenterol Hepatol. 2022 Mar 23.
    View in: PubMed
    Score: 0.248
  2. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2017 05 25; 18(1):234.
    View in: PubMed
    Score: 0.178
  3. Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial. Pain. 2021 09 01; 162(9):2428-2435.
    View in: PubMed
    Score: 0.060
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.